These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28625017)

  • 1. A single-tube flow cytometric procedure for enhancing the diagnosis and prognostic classification of patients with myelodysplastic syndromes.
    Kárai B; Bedekovics J; Miltényi Z; Gergely L; Szerafin L; Ujfalusi A; Kappelmayer J; Hevessy Z
    Int J Lab Hematol; 2017 Dec; 39(6):577-584. PubMed ID: 28625017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
    Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
    Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.
    Della Porta MG; Malcovati L; Invernizzi R; Travaglino E; Pascutto C; Maffioli M; Gallì A; Boggi S; Pietra D; Vanelli L; Marseglia C; Levi S; Arosio P; Lazzarino M; Cazzola M
    Leukemia; 2006 Apr; 20(4):549-55. PubMed ID: 16498394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abnormality of immunophenotyping in patients with myelodysplastic syndrome].
    Xu J; Guo YX; Zhao H; Hui WH; Wan SG; Sun XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):894-7. PubMed ID: 19698224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of a single tube 10-color flow cytometry for quantitative and qualitative analysis in myelodysplastic syndrome- a pilot study.
    Chauhan R; Singh J; Sharma C; Dange P; Chopra A; Mahapatra M; Pati H
    Leuk Res; 2021 Aug; 107():106651. PubMed ID: 34218155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.
    Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
    Br J Haematol; 2014 Oct; 167(1):100-9. PubMed ID: 24976502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes.
    Mathis S; Chapuis N; Debord C; Rouquette A; Radford-Weiss I; Park S; Dreyfus F; Lacombe C; Béné MC; Kosmider O; Fontenay M; Bardet V
    Leukemia; 2013 Oct; 27(10):1981-7. PubMed ID: 23765225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.
    Xu F; Wu L; He Q; Zhang Z; Chang C; Li X
    Intern Med J; 2012 Apr; 42(4):401-11. PubMed ID: 22032631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system.
    Alhan C; Westers TM; Cremers EM; Cali C; Witte BI; Ossenkoppele GJ; van de Loosdrecht AA
    Leukemia; 2016 Mar; 30(3):658-65. PubMed ID: 26503643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advances in value of flow cytometric immunophenotyping in diagnosis and prognostic evaluation of myelodysplastic syndrome].
    Lu D; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):785-90. PubMed ID: 23815941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Ogata K; Sei K; Saft L; Kawahara N; Porta MGD; Chapuis N; Yamamoto Y
    Leuk Res; 2018 Aug; 71():75-81. PubMed ID: 30025279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Multicolor Flow Cytometry Scoring System for the Diagnosis and Prognostic Stratification of Myelodysplastic Syndromes.
    Lai B; Chen Y; Li M; Ye G; Luo H; Zhong Y; Guo X
    Clin Lab; 2022 Sep; 68(9):. PubMed ID: 36125138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.
    Eidenschink Brodersen L; Menssen AJ; Wangen JR; Stephenson CF; de Baca ME; Zehentner BK; Wells DA; Loken MR
    Cytometry B Clin Cytom; 2015 Mar; 88(2):125-35. PubMed ID: 25490867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic application and clinical significance of FCM progress scoring system based on immunophenotyping in CD34+ blasts in myelodysplastic syndromes.
    Xu F; Guo J; Wu LY; He Q; Zhang Z; Chang CK; Li X
    Cytometry B Clin Cytom; 2013; 84(4):267-78. PubMed ID: 23554290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients.
    Mohadese Hashem B; Rajesh R; Sabariah MN; Zainina BS
    Med J Malaysia; 2012 Feb; 67(1):77-80. PubMed ID: 22582553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome.
    Scott BL; Wells DA; Loken MR; Myerson D; Leisenring WM; Deeg HJ
    Blood; 2008 Oct; 112(7):2681-6. PubMed ID: 18606877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):9-17. PubMed ID: 15668954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact.
    Oelschlaegel U; Oelschlaeger L; von Bonin M; Kramer M; Sockel K; Mohr B; Wagenfuehr L; Kroschinsky F; Bornhaeuser M; Platzbecker U
    Cytometry B Clin Cytom; 2023 Mar; 104(2):141-150. PubMed ID: 34390327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.